Matches in SemOpenAlex for { <https://semopenalex.org/work/W1557552070> ?p ?o ?g. }
- W1557552070 endingPage "822" @default.
- W1557552070 startingPage "806" @default.
- W1557552070 abstract "Monoclonal antibodies (mAbs) and fusion proteins directed towards soluble targets make an important contribution to the treatment of disease. The purpose of this review was to correlate the clinical and preclinical data on the 14 currently approved mAbs and fusion proteins targeted to soluble targets. The principal sources used to gather data were: the peer reviewed Literature; European Medicines Agency 'Scientific Discussions' and United States Food and Drug Administration 'Pharmacology/Toxicology Reviews' and package inserts (United States Prescribing Information). Data on the following approved biopharmaceuticals were included: adalimumab, anakinra, bevacizumab, canakinumab, certolizumab pegol, denosumab, eculizumab, etanercept, golimumab, infliximab, omalizumab, ranibizumab, rilonacept and ustekinumab. Some related biopharmaceuticals in late-stage development were also included for comparison. Good concordance with human pharmacodynamics was found for both non-human primates (NHPs) receiving the human biopharmaceutical and mice receiving rodent homologues (surrogates). In contrast, there was limited concordance for human adverse effects in genetically deficient mice, mice receiving surrogates or NHPs receiving the human pharmaceutical. In summary, the results of this survey show that although both mice and NHPs have good predictive value for human pharmacodynamics, neither species have good predictive value for human adverse effects. No evidence that NHPs have superior predictive value was found." @default.
- W1557552070 created "2016-06-24" @default.
- W1557552070 creator A5005663232 @default.
- W1557552070 creator A5035283317 @default.
- W1557552070 date "2012-05-08" @default.
- W1557552070 modified "2023-10-14" @default.
- W1557552070 title "Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets" @default.
- W1557552070 cites W1534645474 @default.
- W1557552070 cites W1545137912 @default.
- W1557552070 cites W1564460371 @default.
- W1557552070 cites W1571914910 @default.
- W1557552070 cites W1594748719 @default.
- W1557552070 cites W1595069888 @default.
- W1557552070 cites W1607447489 @default.
- W1557552070 cites W1916462614 @default.
- W1557552070 cites W1922457932 @default.
- W1557552070 cites W1925130139 @default.
- W1557552070 cites W1926794319 @default.
- W1557552070 cites W1937452056 @default.
- W1557552070 cites W1962094639 @default.
- W1557552070 cites W1966000361 @default.
- W1557552070 cites W1967681366 @default.
- W1557552070 cites W1971124576 @default.
- W1557552070 cites W1971392719 @default.
- W1557552070 cites W1976893749 @default.
- W1557552070 cites W1978315375 @default.
- W1557552070 cites W1981165346 @default.
- W1557552070 cites W1981906652 @default.
- W1557552070 cites W1983597258 @default.
- W1557552070 cites W1984467626 @default.
- W1557552070 cites W1985224469 @default.
- W1557552070 cites W1985521042 @default.
- W1557552070 cites W1985965688 @default.
- W1557552070 cites W1986310612 @default.
- W1557552070 cites W1986843662 @default.
- W1557552070 cites W1992159640 @default.
- W1557552070 cites W1992517723 @default.
- W1557552070 cites W1998824336 @default.
- W1557552070 cites W2004031864 @default.
- W1557552070 cites W2004766005 @default.
- W1557552070 cites W2006471464 @default.
- W1557552070 cites W2008716770 @default.
- W1557552070 cites W2009495078 @default.
- W1557552070 cites W2015460060 @default.
- W1557552070 cites W2020365691 @default.
- W1557552070 cites W2020475710 @default.
- W1557552070 cites W2026419325 @default.
- W1557552070 cites W2027522935 @default.
- W1557552070 cites W2028243710 @default.
- W1557552070 cites W2028672514 @default.
- W1557552070 cites W2030889094 @default.
- W1557552070 cites W2035031252 @default.
- W1557552070 cites W2035187012 @default.
- W1557552070 cites W2035634351 @default.
- W1557552070 cites W2036644073 @default.
- W1557552070 cites W2042607730 @default.
- W1557552070 cites W2044617562 @default.
- W1557552070 cites W2046334928 @default.
- W1557552070 cites W2047743628 @default.
- W1557552070 cites W2051320963 @default.
- W1557552070 cites W2052514275 @default.
- W1557552070 cites W2052688737 @default.
- W1557552070 cites W2056125998 @default.
- W1557552070 cites W2057873052 @default.
- W1557552070 cites W2059670547 @default.
- W1557552070 cites W2061294496 @default.
- W1557552070 cites W2063053561 @default.
- W1557552070 cites W2065791817 @default.
- W1557552070 cites W2069499812 @default.
- W1557552070 cites W2070576387 @default.
- W1557552070 cites W2071099746 @default.
- W1557552070 cites W2074301535 @default.
- W1557552070 cites W2074477433 @default.
- W1557552070 cites W2076683648 @default.
- W1557552070 cites W2076934000 @default.
- W1557552070 cites W2079528410 @default.
- W1557552070 cites W2081680826 @default.
- W1557552070 cites W2083816793 @default.
- W1557552070 cites W2083945266 @default.
- W1557552070 cites W2088428578 @default.
- W1557552070 cites W2090437073 @default.
- W1557552070 cites W2090712553 @default.
- W1557552070 cites W2090763994 @default.
- W1557552070 cites W2093498435 @default.
- W1557552070 cites W2096175009 @default.
- W1557552070 cites W2098155102 @default.
- W1557552070 cites W2099919027 @default.
- W1557552070 cites W2102975355 @default.
- W1557552070 cites W2110558489 @default.
- W1557552070 cites W2111604100 @default.
- W1557552070 cites W2112463958 @default.
- W1557552070 cites W2112529242 @default.
- W1557552070 cites W2118881364 @default.
- W1557552070 cites W2124180683 @default.
- W1557552070 cites W2126522226 @default.
- W1557552070 cites W2127472868 @default.
- W1557552070 cites W2130652971 @default.
- W1557552070 cites W2132682137 @default.